Intrinsic Value of S&P & Nasdaq Contact Us

STERIS plc STE NYSE

NYSE • Healthcare • Medical - Devices • IE • USD

SharesGrow Score
76/100
4/7 Pass
SharesGrow Intrinsic Value
$221.37
-1.5%
Analyst Price Target
$256.67
+14.2%

STERIS plc (STE) generated $1.15B in operating cash flow for fiscal year 2025. After capital expenditures of $370.09M, free cash flow was $778M.

Free cash flow margin was 14.3% of revenue. Cash conversion ratio was 1.86x, indicating earnings are backed by cash.

The company returned $219.88M in dividends to shareholders during the period.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (69/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (55/100) — Cash conversion ratio was 1.86x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 76/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
76/100
SG Score
View full scorecard →
~
VALUE
41/100
Price-to-Earnings & upside
→ Valuation
FUTURE
82/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
69/100
Proven by this page
GROWTH
83/100
→ Income
~
INCOME
55/100
→ Income
STERIS plc Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $1.27B$1.15B$973.27M$756.95M$684.81M
Capital Expenditure $-349.69M$-370.09M$-360.33M$-361.97M$-287.56M
Free Cash Flow $919.41M$778M$612.95M$394.98M$397.25M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message